Last updated on August 2018

A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women


Brief description of study

A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women

Detailed Study Description

A clinical trial is enrolling patients with Uterine Fibroids.

Clinical Study Identifier: TX142206

Find a site near you

Start Over

Manhattan Medical Research

215 Lexington Ave. 21st Floor New York, NY USA
  Connect »